Biotechnology has quiet possibly been the weakest sector over the last six months, underperforming almost everything else by a ton. However, there may be light at the end of the tunnel.
The $IBB (biotech ETF) is nearing a key breakout above the daily 50MA on the daily chart. Should it close above today, a short squeeze could begin in the coming days. Upside max target would be $300.00. Please note the chart below and remember, it MUST close above the 50 day moving average.
Gareth Soloway
Chief Market Strategist
InTheMoneyStocks.com